GBA Group Pharma Revenue and Competitors

Europe, Germany

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • GBA Group Pharma's estimated annual revenue is currently $21.9M per year.(i)
  • GBA Group Pharma's estimated revenue per employee is $201,000

Employee Data

  • GBA Group Pharma has 109 Employees.(i)
  • GBA Group Pharma grew their employee count by -1% last year.

GBA Group Pharma's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$17.7M887%N/AN/A
#2
$89.4M4459%N/AN/A
#3
$32.4M16125%N/AN/A
#4
$44.4M2217%N/AN/A
#5
$120.2M42717%$446.2MN/A
#6
$54.3M27010%N/AN/A
#7
$49.6M24752%N/AN/A
#8
$21.9M109-1%N/AN/A
#9
$16.5M824%N/AN/A
#10
$26.7M13325%N/AN/A
Add Company

What Is GBA Group Pharma?

From early lead optimization and early preclinical stage to global clinical studies, GBA Group Pharma supports clients throughout the entire lifecycle with central laboratory, GMP Depots, EU GMP manufacturing site for labeling and packaging and QP services, as well as late drug development and analytical services including import testing and QP batch release. GBA Group Pharma is a fully Brexit Proof Organisation as all facilities and QPs are located in mainland Europe. 4 Established European Companies are Members of GBA Group Pharma: - Pharmacelsus - ABF Pharmaceutical Services - LKF Laboratory for Clinical Trials - GBA Pharma Labs The Members of GBA Group Pharma have an excellent track record in serving client needs and broad experience in handling small molecules as well as larger molecules, therapeutic peptides, biologics and cell based therapies and also ATMPs.

keywords:N/A

N/A

Total Funding

109

Number of Employees

$21.9M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

GBA Group Pharma News

2022-04-06 - Improved Survival With Enzalutamide in Patients With ...

... plus ADT (median not reached in either group; hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P < .001). ... Expert Testimony: GBA Pharma.

2022-04-06 - Intrinsic Medicine: Leveraging Human Identical Milk Oligosaccharides

Get them exclusively at The Total Pharma Tracker. ... to develop targeted new drugs for treating specific gut-brain axis ('GBA) disorders.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A15148%N/A
#2
$93.2M3558%N/A
#3
$93.2M3558%N/A
#4
N/A108717%N/A